Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Total Dose Infusion of Low Molecular Weight (LMW) Iron Dextran in a Large Population of Anemic Patients Across a Broad Spectrum of Diagnoses Associated with Iron Lack

Tahir Mehmood, MD, Khine Swe, MD, Gopimohan Das, MD, Aysegul Gozu, MD MPH, Michael Auerbach, MD, Sein Aung, MD

Blood (2014) 124 (21): 4028.

https://doi.org/10.1182/blood.V124.21.4028.4028

Published: 2014

Journal Articles

Pediatric Myelodysplastic Syndrome: Experience from a Single Center

Mualla Cetin, MDProf, Sule Unal, MD, Turan Bayhan, Selin Aytac, Baris Kuskonmaz, Betul Tavil, Duygu Uckan-Cetinkaya, Fatma Gumruk, MDProf, A. Murat Tuncer, MD

Blood (2014) 124 (21): 5604.

https://doi.org/10.1182/blood.V124.21.5604.5604

Published: 2014

Journal Articles

Successful Stem Cell Tranplant Following HLA Identical Sibling Selection Using PGD Combined With HLA Typing In a Case Of CD40 Ligand Deficiency

Nazia Tabassum, MD, Celia Gonzalez, PA-C, Karen Anthony, RN, Jignesh Dalal, MD

Blood (2013) 122 (21): 4514.

https://doi.org/10.1182/blood.V122.21.4514.4514

Published: 2013

Journal Articles

Elotuzumab In Combination with Lenalidomide and Low-Dose Dexamethasone In Patients with Relapsed/Refractory Multiple Myeloma: Interim Results of a Phase 1 Study

Sagar Lonial, MD, Ravi Vij, MD, Jean-Luc Harousseau, MD, Thierry Facon, MD, Philippe Moreau, MD, Xavier Leleu, MD, PhD, Amitabha Mazumder, MD, Jonathan L Kaufman, MD, Christopher E Westland, Claire Tsao, PhD, Anil K Singhal, MD, Sundar Jagannath, MD

Blood (2010) 116 (21): 1936.

https://doi.org/10.1182/blood.V116.21.1936.1936

Published: 2010

Journal Articles

Waldenstrom's Microglobulinemia Presenting with Recurrent Angioedema Secondary to C1q Esterase Inhibitor (C1 INH) Deficiency

Nneamaka N Enwemnwa, MD, Abhinav B. Chandra, MD, MSc, Porselvi Chockalingam, MD, Jack Burton, MD

Blood (2010) 116 (21): 5009.

https://doi.org/10.1182/blood.V116.21.5009.5009

Published: 2010

Journal Articles

Elotuzumab In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed Multiple Myeloma: Interim Results of a Phase 2 Study

Paul G. Richardson, MD, Philippe Moreau, MD, Andrzej J Jakubowiak, MD, PhD, Thierry Facon, MD, Sundar Jagannath, MD, Ravi Vij, MD, Donna E Reece, MD, Darrell J White, MD, Marc S Raab, MD, PhD, Lotfi Benboubker, MD, PhD, Jean-Francois Rossi, MD, PhD, Claire Tsao, PhD, John Fry, David Berman, MD, PhD, Anil K Singhal, MD, Sagar Lonial, MD

Blood (2010) 116 (21): 986.

https://doi.org/10.1182/blood.V116.21.986.986

Published: 2010

NARROW

Safety and Efficacy of Total Dose Infusion of Low Molecular Weight (LMW) Iron Dextran in a Large Population of Anemic Patients Across a Broad Spectrum of Diagnoses Associated with Iron Lack

Pediatric Myelodysplastic Syndrome: Experience from a Single Center

Successful Stem Cell Tranplant Following HLA Identical Sibling Selection Using PGD Combined With HLA Typing In a Case Of CD40 Ligand Deficiency

Elotuzumab In Combination with Lenalidomide and Low-Dose Dexamethasone In Patients with Relapsed/Refractory Multiple Myeloma: Interim Results of a Phase 1 Study

Waldenstrom's Microglobulinemia Presenting with Recurrent Angioedema Secondary to C1q Esterase Inhibitor (C1 INH) Deficiency

Elotuzumab In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed Multiple Myeloma: Interim Results of a Phase 2 Study

Email alerts

ASH Publications

American Society of Hematology

Safety and Efficacy of Total Dose Infusion of Low Molecular Weight (LMW) Iron Dextran in a Large Population of Anemic Patients Across a Broad Spectrum of Diagnoses Associated with Iron Lack

Pediatric Myelodysplastic Syndrome: Experience from a Single Center

Successful Stem Cell Tranplant Following HLA Identical Sibling Selection Using PGD Combined With HLA Typing In a Case Of CD40 Ligand Deficiency

Elotuzumab In Combination with Lenalidomide and Low-Dose Dexamethasone In Patients with Relapsed/Refractory Multiple Myeloma: Interim Results of a Phase 1 Study

Waldenstrom's Microglobulinemia Presenting with Recurrent Angioedema Secondary to C1q Esterase Inhibitor (C1 INH) Deficiency

Elotuzumab In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed Multiple Myeloma: Interim Results of a Phase 2 Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only